ESC Premium Access

Copper chelation in hypertrophic cardiomyopathy; open-label pilot study assessing the effects of trientine on lv mass, myocardial fibrosis, performance and metabolism.

Congress Presentation

About the speaker

Doctor Anna Reid

Manchester University NHS Foundation Trust, Manchester (United Kingdom of Great Britain & Northern Ireland)
1 follower

26 more presentations in this session

Sleep apnea diagnosis by using polysomnography may improve individual risk stratification in patients with hypertrophic cardiomyopathy

Speaker: Associate Professor T. Kara (Rochester, US)

Thumbnail

Myocardial bridging in patients with apical hypertrophic cardiomyopathy

Speaker: Doctor S. Zhai (Beijing, CN)

Thumbnail

Accuracy of LGE-CMR compared with histometric quantification of myocardial fibrosis in transplanted hearts of end-stage HCM

Speaker: Doctor G. Galati (Milan, IT)

Thumbnail

Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy - a longitudinal study

Speaker: Doctor A. Axelsson Raja (Copenhagen, DK)

Thumbnail

Prognostic role of myocardial edema at cardiac magnetic resonance in hypertrophic cardiomyopathy.

Speaker: Doctor G. Todiere (Pisa, IT)

Thumbnail

Access the full session

Poster session 5 - Cardiomyopathy

Speakers: Doctor A. Reid, Associate Professor T. Kara, Doctor S. Zhai, Doctor G. Galati, Doctor A. Axelsson Raja...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk